From Prescription to Patient: Navigating Barriers to HCV Treatment Initiation

Objectives

  • Describe the financial impact of HCV treatment
  • Identify current restrictions to HCV treatment common among third party payers
  • Illustrate successful navigation through the prior authorization and appeal process
  • Review criteria and options for patient assistance programs (PAP)

Speaker

Autumn Bagwell PharmD BCPS

Check all that apply
Check all that apply

Add comment

Log in to post comments